Long-Term Effectiveness and Safety of Treatment With Deucravacitinib in Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Long-term effectiveness and safety of deucravacitinib in psoriasis: A 52-week real-world study of genital, scalp, and nail lesions
Clin Exp Dermatol 2024 Dec 06;[EPub Ahead of Print], T Hagino, H Saeki, E Fujimoto, N KandaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.